Related Experiment Video
Updated: Jan 14, 2026
05:47
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
8.0K
CaMK4, a key target for treating pathogenesis of depression?
Yang Yang1, Wei Guan2, Hai-Juan Gu1
1Department of Pharmacy, Affiliated Tumor Hospital of Nantong University/Nantong Tumor Hospital, China.
Biochemical Pharmacology
|October 19, 2025
Summary
Calcium/calmodulin-dependent protein kinase IV (CaMK4) is implicated in depression pathogenesis. Dysregulation of CaMK4 signaling impacts neural development and synaptic plasticity, offering potential for new antidepressant drug development.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Depression is a prevalent mental disorder linked to chronic stress.
- The precise mechanisms of stress-induced depression remain unclear.
- Calcium/calmodulin-dependent protein kinase IV (CaMK4) is a key signaling molecule in various cell types.
Purpose of the Study:
- To review the role of CaMK4 in the pathogenesis of depression.
- To explore the molecular involvement of CaMK4 in depression.
- To highlight CaMK4's impact on neural development and synaptic plasticity.
Main Methods:
- Literature review of studies on CaMK4 and depression.
- Analysis of CaMK4's role in gene expression and cellular signaling.
- Examination of CaMK4's influence on hippocampal neurogenesis and synaptic plasticity.
Main Results:
- CaMK4 is a crucial mediator in Ca2+-calmodulin signaling pathways.
- CaMK4 plays a significant role in neural development and synaptic plasticity.
- Impairments in CaMK4 function are associated with depression.
Conclusions:
- CaMK4 is a core component in the development of depression.
- Dysregulation of CaMK4 signaling contributes to depression.
- Understanding CaMK4's role may lead to novel antidepressant therapies.
Related Concept Videos
01:18Depression: Overview
777
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
777
01:25cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
01:27Depressive Disorders: Etiology
437
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
437
01:25Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
01:23Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
02:15M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K